1. Home
  2. SCYX vs PHUN Comparison

SCYX vs PHUN Comparison

Compare SCYX & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$2.97

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo Phunware Inc.

PHUN

Phunware Inc.

SELL

Current Price

$1.67

Market Cap

42.6M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
SCYX
PHUN
Founded
1999
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
42.6M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
SCYX
PHUN
Price
$2.97
$1.67
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $32.67
N/A
AVG Volume (30 Days)
★ 59.4K
48.0K
Earning Date
11-05-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.36
39.36
EPS
N/A
★ N/A
Revenue
$257,000.00
★ $30,883,000.00
Revenue This Year
N/A
$37.21
Revenue Next Year
$977.86
$1,931.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 15.57
52 Week Low
$0.66
$1.56
52 Week High
$6.09
$2.30

Technical Indicators

Market Signals
Indicator
SCYX
PHUN
Relative Strength Index (RSI) 26.17 28.55
Support Level $0.66 $1.64
Resistance Level $4.15 $2.27
Average True Range (ATR) 0.25 0.07
MACD -0.04 -0.01
Stochastic Oscillator 4.17 3.57

Price Performance

Historical Comparison
SCYX
PHUN

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.

Share on Social Networks: